Hemoglobin testing matters if you experience persistent fatigue, shortness of breath with normal activity, pale skin, dizziness, or cognitive fog — all classic signs of inadequate oxygen delivery to tissues. It also matters if you menstruate (significant iron loss), follow a restrictive diet, have digestive malabsorption, or have a family history of anemia or blood disorders. Men with low hemoglobin always warrant further investigation, including gastrointestinal evaluation, because iron loss in men typically signals bleeding.

Beyond acute anemia detection, hemoglobin at the lower bound of “normal” often masks functional iron deficiency — your iron stores are depleted even though hemoglobin appears acceptable. This pattern is especially common in menstruating women and is a major cause of unexplained fatigue and cognitive decline in otherwise healthy people. Testing hemoglobin alongside ferritin reveals this hidden deficit.

Hemoglobin is a core longevity marker because low oxygen delivery accelerates aging, impairs mitochondrial function, and drives pathology in the brain, heart, and muscle. High hemoglobin (polycythemia) signals dehydration, hypoxia, or erythropoietin-driven disease, all of which warrant investigation.

• Measures oxygen-carrying capacity directly. Hemoglobin is the single most important protein for systemic oxygen delivery. A hemoglobin test quantifies your blood's ability to bind and transport oxygen to every cell in your body, revealing whether metabolic energy production is compromised.

• Flags functional iron deficiency early. Iron deficiency anemia develops in stages: iron stores deplete first (ferritin falls), then iron transport drops (transferrin saturation falls), then hemoglobin finally falls. Normal hemoglobin does not rule out iron deficiency if ferritin is low — a critical insight for preventing progressive dysfunction.

• Reveals hidden fatigue and cognitive decline causes. Hemoglobin at the lower end of normal (e.g., 125 g/L in a woman when optimal is 140–150) commonly underlies unexplained fatigue, reduced exercise capacity, poor sleep quality, and cognitive fog. This pattern is widespread and often missed because the result is “normal.”

• Guides interpretation with MCV (cell size). Paired with mean corpuscular volume (MCV), hemoglobin reveals the type of anemia: microcytic (small cells, usually iron deficiency or thalassemia), macrocytic (large cells, usually B12/folate/alcohol/thyroid dysfunction), or normocytic (normal-sized cells, usually acute bleeding or chronic disease). This classification directs further workup.

• Detects polycythemia and erythropoietin dysfunction. High hemoglobin signals dehydration, chronic hypoxia, testosterone therapy, or erythropoietin-secreting tumours. These conditions carry cardiovascular risk and demand investigation.

• Tracks response to supplementation or dietary intervention. Hemoglobin responds reliably to iron repletion, B12 restoration, or improved dietary intake. Monitoring hemoglobin and ferritin together shows whether interventions are working and at what pace.

The oxygen-carrying architecture. Hemoglobin is a protein inside red blood cells composed of four globin chains, each with an iron-containing heme group at its centre. Each heme binds one oxygen molecule; thus each hemoglobin molecule carries four oxygen atoms. In the lungs, hemoglobin picks up oxygen and becomes bright red (oxyhemoglobin). In tissues, it releases that oxygen to fuel aerobic metabolism in mitochondria, and becomes darker (deoxyhemoglobin). This cycle repeats billions of times per day in healthy individuals.

Why iron deficiency halts hemoglobin production. Iron is essential for heme synthesis. Without adequate iron, the bone marrow cannot manufacture hemoglobin at normal rates, even if the raw materials (amino acids for globin chains) are abundant. Iron stores (measured by ferritin) are the buffer — the marrow draws on them to maintain hemoglobin production during periods of inadequate iron intake. When stores run out, production slows, and hemoglobin eventually falls. This is why women who menstruate are at highest risk: monthly blood loss drains iron stores faster than dietary intake typically replenishes them, particularly if diet is low in bioavailable iron (red meat, fish, legumes).

How to interpret low hemoglobin in context of MCV. The mean corpuscular volume (MCV) — the average size of a red blood cell — is the key diagnostic lens. Microcytic anaemia (low hemoglobin + small cells) typically indicates iron deficiency or thalassemia trait. Macrocytic anaemia (low hemoglobin + large cells) indicates B12 or folate deficiency, alcohol-related marrow dysfunction, or thyroid disease. Normocytic anaemia (low hemoglobin + normal cell size) suggests acute bleeding, chronic disease (kidney failure, malignancy, chronic inflammation), or bone marrow suppression. Always interpret hemoglobin with MCV and ferritin to narrow the diagnosis.

• Identifies hidden functional iron deficiency. A hemoglobin of 130 g/L in a woman with ferritin of 15 µg/L represents functional iron deficiency — iron stores are depleted, and hemoglobin production is already constrained. She may feel fine at rest, but oxygen delivery during exercise or cognitive load is compromised. Her mitochondria are working harder to extract oxygen from each red blood cell. Over time, this chronic hypoxia accelerates aging and impairs cognitive performance. Testing ferritin alongside hemoglobin catches this pattern before symptoms become severe.

• Prevents progressive anemia and its cascade effects. Low hemoglobin reduces oxygen delivery to the brain, heart, and skeletal muscle. Chronically low hemoglobin (<120 g/L in women, <130 g/L in men) accelerates cardiovascular disease risk, worsens exercise capacity, impairs cognitive function, and slows metabolic rate. Progressive anemia is not inevitable — catching it early via hemoglobin testing and investigating the cause (iron loss, malabsorption, dietary insufficiency, chronic disease) allows intervention before disability develops.

• Reveals gastrointestinal pathology in men. A man with low hemoglobin has lost blood somewhere, most commonly from gastrointestinal bleeding (peptic ulcer, Barrett’s oesophagus, polyps, colorectal cancer). Hemoglobin testing in men is not optional — it is a screening tool for occult GI pathology. Any man with low hemoglobin requires GI evaluation.

• Detects erythropoietin and hypoxia signalling dysfunction. High hemoglobin (polycythemia) indicates either dehydration (a transient confounder) or a pathological state: chronic hypoxia (lung disease, high altitude), erythropoietin-secreting tumour, or polycythemia vera (bone marrow malignancy). These conditions carry significant cardiovascular and thrombotic risk and must be investigated.

• Standard Swedish clinical reference (vårdcentralen): Men 130–170 g/L; women 120–150 g/L. Values within this range are reported as “normal,” but the width of this range masks functional insufficiency at the lower end.

• Loovi optimal (longevity baseline): Men 140–160 g/L; women 130–150 g/L. This narrower, higher band reflects the hemoglobin levels associated with optimal aerobic capacity, cognitive performance, and mitochondrial function. People at this level report better energy, exercise capacity, and mental clarity than those at the lower end of the “normal” range.

• Aggressive (for individuals with cardiovascular disease or high-altitude living): Men 145–160 g/L; women 135–150 g/L. Athletes, people at altitude, or those with established cardiovascular disease benefit from hemoglobin in the upper-optimal range to maximize oxygen delivery under stress.

The step from 120 to 130 g/L in women represents a meaningful shift in oxygen delivery capacity; women at 120 g/L often report fatigue and reduced exercise capacity compared to those at 140 g/L, even though both are “normal.” For longevity, aiming for the upper-optimal range is most aligned with sustained energy, cognitive performance, and cardiovascular health.

Low (<120 g/L in women, <130 g/L in men). This indicates anaemia — inadequate oxygen-carrying capacity. Symptoms may include fatigue, shortness of breath with exertion, reduced exercise capacity, cognitive fog, pale skin, or rapid heartbeat. The cause must be identified: iron deficiency (check ferritin and serum iron), B12 or folate deficiency (check B12 and methylmalonic acid), chronic disease (kidney failure, cancer, chronic inflammation), acute bleeding, or bone marrow suppression. In men, low hemoglobin is abnormal and warrants gastrointestinal investigation. In menstruating women, iron deficiency is the most common cause; in post-menopausal women or men, investigate more broadly.

Low-normal but suboptimal (120–135 g/L in women; 130–140 g/L in men). This is the “normal” range by standard lab reporting, but at the lower end it often masks functional iron deficiency or early-stage anaemia. If ferritin is also low (<30 µg/L), iron stores are depleted and oxygen delivery is compromised, even if hemoglobin hasn’t fallen formally into the anaemic range. People in this zone commonly report fatigue, poor exercise capacity, and reduced cognitive clarity. Intervention (dietary iron, supplementation, investigation for occult bleeding) is warranted if ferritin is low.

Optimal (135–160 g/L in women; 140–160 g/L in men). This is the target zone for longevity. Oxygen delivery is robust, mitochondrial function is well-supported, and energy and cognitive performance are typically excellent. Paired with ferritin >50 µg/L, this level is associated with sustained health and vitality.

High (>160 g/L in women, >170 g/L in men). This is polycythaemia and warrants investigation. Transient elevation can occur from dehydration (recheck after adequate hydration). Persistent elevation suggests chronic hypoxia (lung disease, sleep apnoea, high-altitude residence), erythropoietin-secreting tumour, testosterone therapy, or polycythemia vera (bone marrow malignancy). High hemoglobin increases blood viscosity and thrombotic risk; investigation is necessary.

Factors that influence hemoglobin. Altitude (chronic hypoxia upregulates erythropoietin and raises hemoglobin over weeks to months). Dehydration artificially concentrates hemoglobin; retest after rehydration for an accurate baseline. Menstrual cycle and pregnancy both affect hemoglobin (pregnancy typically lowers it 10–15% due to plasma expansion). Recent intense exercise or blood donation temporarily lowers hemoglobin; wait 4–6 weeks for full recovery. Chronic smoking elevates hemoglobin due to hypoxia signalling. Testosterone therapy (in any sex) elevates hemoglobin; monitor accordingly.

• Iron deficiency from inadequate intake or excessive loss. In menstruating women, monthly blood loss is the primary driver. Dietary iron insufficiency (particularly in vegetarian or vegan diets low in highly bioavailable iron from meat, fish, and shellfish) exacerbates this. Malabsorption (coeliac disease, inflammatory bowel disease, atrophic gastritis, post-bariatric surgery) prevents iron uptake despite adequate intake. Chronic blood loss from peptic ulcers, polyps, hemorrhoids, or occult gastrointestinal bleeding (especially in men) depletes stores progressively.

• Vitamin B12 or folate deficiency. B12 is required for DNA synthesis in erythroid progenitors; deficiency halts red cell production and causes macrocytic anaemia. Sources include animal products (meat, fish, eggs, dairy); vegans are at high risk. Pernicious anaemia (autoimmune B12 malabsorption) and atrophic gastritis (age-related loss of intrinsic factor) are common in older adults. Folate deficiency (from inadequate leafy greens, legumes, or whole grains, or from anticonvulsants and methotrexate) causes similar macrocytic anaemia.

• Chronic disease, inflammation, or kidney failure. Chronic kidney disease reduces erythropoietin production, halting red cell formation. Chronic infection (tuberculosis, endocarditis), malignancy, or autoimmune disease (rheumatoid arthritis, lupus) trigger systemic inflammation that suppresses erythropoietin signalling and causes anaemia of chronic disease (typically normocytic). Liver disease impairs iron metabolism.

• Bone marrow suppression or genetic blood disorders. Chemotherapy, radiation, autoimmune destruction (autoimmune haemolytic anaemia), or aplastic anaemia can suppress red cell production. Thalassaemia trait (inherited microcytosis) causes low hemoglobin with small cells despite adequate iron. Hereditary spherocytosis and G6PD deficiency cause haemolysis (premature red cell destruction).

• High hemoglobin from altitude, hypoxia, testosterone therapy, or polycythaemia vera. Erythropoietin-secreting tumours (renal cell carcinoma, hepatocellular carcinoma, cerebellar haemangioblastoma) drive polycythaemia. Polycythaemia vera is a myeloproliferative disorder with JAK2 mutation causing uncontrolled red cell production. Dehydration transiently raises hemoglobin concentration.

Iron nutrition and bioavailability. Dietary iron exists in two forms: haem iron (meat, fish, shellfish) is highly bioavailable (~25% absorption); non-haem iron (legumes, leafy greens, fortified grains) is less bioavailable (~5–10%), but absorption increases if paired with vitamin C (citrus, berries, peppers). Red meat, organ meats (liver, kidney), and shellfish are the most concentrated iron sources. For vegetarians and vegans, combining iron-rich foods (lentils, chickpeas, tofu, quinoa, dark leafy greens) with vitamin C sources, and avoiding tannins (tea, coffee) at mealtimes, maximizes absorption. Phytate-reducing practices (soaking, sprouting) improve plant iron availability. Menstruating women and vegans often require supplemental iron; ferritin tracking guides dosing.

Supplementation (when indicated). If ferritin is low (<30 µg/L) and hemoglobin is dropping, iron supplementation (typically 150–300 mg elemental iron daily as ferrous sulphate, gluconate, or bisglycinate) rebuilds stores over 2–6 months. Absorption is better on an empty stomach, but GI upset (nausea, constipation) often requires taking with food; vitamin C enhances absorption. If B12 is low, supplementation (injections, tablets, or sublingual) is necessary for vegetarians, vegans, or those with malabsorption. Folate repletion (from leafy greens, legumes, or fortified grains) or supplementation addresses folate deficiency.

Address underlying cause of anaemia. If iron deficiency is from gastrointestinal bleeding, identifying and treating the source (peptic ulcer, polyp, malignancy) is essential; supplementation alone will not address the loss. If anaemia is from chronic kidney disease, erythropoietin replacement (prescription) or management of underlying renal dysfunction is necessary. If anaemia reflects chronic inflammation or malignancy, treating the primary condition is the priority.

Optimize haematocrit and MCV context. A hemoglobin of 140 g/L is only meaningful if MCV (cell size) and haematocrit (proportion of blood volume occupied by red cells) are also healthy. If MCV is low (microcytic) despite normal hemoglobin, iron deficiency is progressing and ferritin should be checked. The full picture — hemoglobin, MCV, hematocrit, ferritin, serum iron, and transferrin saturation — guides optimal interpretation and intervention.

The right approach depends on the individual’s hemoglobin baseline, ferritin status, MCV pattern, age, menstrual status, and dietary intake — precisely the kind of personalized assessment that a Loovi longevity doctor conducts in consultation to distinguish simple iron deficiency from chronic disease, B12 malabsorption, or other aetiologies.

Hemoglobin tells you the total oxygen-carrying capacity, but it does not tell you why. A hemoglobin of 130 g/L could reflect iron deficiency (check ferritin and serum iron), B12 deficiency (check B12 and methylmalonic acid), chronic kidney disease (check creatinine and eGFR), chronic inflammation (check hs-CRP), malignancy, or early-stage bone marrow failure. Without ferritin, MCV, B12, and hematocrit, you cannot diagnose the cause or prescribe the right intervention. Similarly, high hemoglobin requires knowing whether it is transient dehydration (retest after hydration), altitude adaptation, erythropoietin-secreting disease, or polycythaemia vera — each with vastly different implications.

The Loovi Membership measures 120+ biomarkers annually, including the complete iron panel (hemoglobin, ferritin, serum iron, transferrin saturation), red cell morphology (MCV, mean corpuscular haemoglobin, RBC count, hematocrit), and B vitamins (B12, folate, methylmalonic acid). Paired with unrushed 1-on-1 longevity doctor consultations, physical performance tests (strength, mobility, VO2 max), and an evolving personalized health plan, Loovi hands off the hard work of interpretation and personalization to clinical experts. From 295 SEK/month, Friskvårdsbidrag-approved, with drop-in testing at 80+ Swedish clinics and results in 3 days.